Literature DB >> 1852918

Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.

J J Mazeron1, J M Simon, C Le Péchoux, J M Crook, L Grimard, P Piedbois, J P Le Bourgeois, B Pierquin.   

Abstract

From 1971 to 1988, 134 T1 and 145 T2 biopsy-proven squamous cell carcinomas of mobile tongue and floor of mouth were definitively managed by iridium-192. Implantations were performed using either guide gutters or afterloading plastic catheters. The prescribed dose at the reference isodose (85% of the basal dose rate, Paris system) was 60-70 Gy. Total dose was not adjusted to dose rate or tumor volume. Results of the 279 implants have been analysed to look for a possible influence of dose rate on local control and necrosis. Follow-up patients free of local recurrence is 1-180 months with average of 51 months. The 279 tumors were divided in four groups according to dose and dose rate: greater than or equal to 62.5 Gy and greater than or equal to 0.5 Gy/h (n = 130), greater than or equal to 62.5 Gy and less than 0.5 Gy/h (n = 36), less than 62.5 Gy and greater than or equal to 0.5 Gy/h (n = 81), less than 62.5 Gy and less than 0.5 Gy/h (n = 32). The four groups were comparable according to age, sex, tumor diameter and macroscopic aspect. At 5 years, the estimated local control (Kaplan Meier) was 93, 87, 79 and 52%, respectively (dose adjusted to dose rate: p less than 0.001, dose rate adjusted to dose: p less than 0.01, Log-rank); the necrosis rate was 44, 24, 37 and 5%, respectively (dose adjusted to dose rate: p = 0.08, dose rate adjusted to dose: p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852918     DOI: 10.1016/0167-8140(91)90339-i

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Intracavitary brachytherapy for carcinoma of the uterine cervix--comparison of HDR (Ir-192) and MDR (Cs-137).

Authors:  Eiichi Tanaka; Osamu Suzuki; Ryoong-Jin Oh; Takashi Takeda; Teruki Teshima; Toshihiko Inoue; Takehiro Inoue
Journal:  Radiat Med       Date:  2006-01

Review 2.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

3.  [Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].

Authors:  R E Friedrich; A Krüll; R Schwarz; H Thurmann; K Plambeck; R Schmelzle
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

4.  Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines.

Authors:  Rajendra Bhalavat; Ashwini Budrukkar; Sarbani Ghosh Laskar; Dayanand Sharma; Ashutosh Mukherji; Manish Chandra; Umesh Mahantshetty; Vibhay Pareek; Pratibha Bauskar; Sonali Saraf
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

5.  Evaluation of neuropathic pain occurring after high-dose-rate interstitial brachytherapy of oral tongue.

Authors:  Vijai Simha; Suresh C Sharma; Rakesh Kapoor; Chirag K Ahuja; Arun S Oinam; Sushmita Ghoshal
Journal:  J Contemp Brachytherapy       Date:  2015-04-01

Review 6.  Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.

Authors:  György Kovács
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

Review 7.  High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer.

Authors:  Alfredo Polo
Journal:  J Contemp Brachytherapy       Date:  2010-01-13

8.  Comparison of radiobiological parameters for 90Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro.

Authors:  Yaser H Gholami; Kathy P Willowson; Nicholas J Forwood; Rozelle Harvie; Nicholas Hardcastle; Regina Bromley; HyunJu Ryu; Samuel Yuen; Viive M Howell; Zdenka Kuncic; Dale L Bailey
Journal:  EJNMMI Phys       Date:  2018-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.